Page last updated: 2024-08-21

ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid) and Experimental Mammary Neoplasms

ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid) has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hunt, FC1

Other Studies

1 other study(ies) available for ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid) and Experimental Mammary Neoplasms

ArticleYear
Chelator-induced enhancement of 67Ga tumour imaging: comparison of desferrioxamine with N,N'-ethylene-bis[2-hydroxy-5-carboxyphenylglycine].
    International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1988, Volume: 15, Issue:6

    Topics: Animals; Chelating Agents; Citrates; Citric Acid; Deferoxamine; Ethylenediamines; Leukemia, Lymphoid; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radionuclide Imaging; Tissue Distribution

1988